• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

时间窗和“组织窗”:两种辅助脑卒中决策的方法。

Time window and "tissue window": two approaches to assist decision-making in strokes.

机构信息

Department of Neurology, Union Hospital Affiliated with Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue in Hankou, Wuhan, 430022, China.

出版信息

J Neurol. 2019 Feb;266(2):283-288. doi: 10.1007/s00415-018-8933-5. Epub 2018 Jun 19.

DOI:10.1007/s00415-018-8933-5
PMID:29922951
Abstract

Intravenous alteplase given in an appropriate time window has been recommended in guidelines and effects are on the decline over time. In general, the clinical decision is primarily based on whether ischemic stroke patients are sent to hospitals within the time window. However, some patients sent to the hospital over time limitations are eligible to receive intervention for recanalization due to good collateral circulation. In this dilemma, "tissue window" can be more reliable, which means using the penumbra as a major criterion for patient recruitment. Hence, we herein aim to address how could "tissue window" be a complementary approach when it does not conform to the time window's indication and affirming value of the later one. Some efforts obeying the time window are discussed first. In the later sections, we give the details of the definition of "tissue window", and then compare various neuroimaging techniques to determine the penumbra and summarize favorable patterns. Finally, we will focus on how the "tissue window" extends the therapeutic time window under specific circumstances.

摘要

静脉注射阿替普酶在适当的时间窗内已被推荐用于指南中,并且其效果随着时间的推移而下降。一般来说,临床决策主要基于缺血性脑卒中患者是否在时间窗内被送往医院。然而,一些超过时间限制但仍有良好侧支循环的患者有资格接受再通干预。在这种困境中,“组织窗”可能更可靠,这意味着将半影区作为患者招募的主要标准。因此,我们旨在探讨当“组织窗”不符合时间窗的适应证时,它如何成为一种补充方法,并肯定后者的价值。首先讨论了一些遵守时间窗的努力。在后面的部分中,我们给出了“组织窗”的定义的详细信息,然后比较了各种神经影像学技术来确定半影区,并总结了有利的模式。最后,我们将重点关注“组织窗”如何在特定情况下扩展治疗时间窗。

相似文献

1
Time window and "tissue window": two approaches to assist decision-making in strokes.时间窗和“组织窗”:两种辅助脑卒中决策的方法。
J Neurol. 2019 Feb;266(2):283-288. doi: 10.1007/s00415-018-8933-5. Epub 2018 Jun 19.
2
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
3
IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon?急性缺血性卒中的静脉溶栓治疗:即将出现模式转变吗?
Neurology. 2016 Jul 12;87(2):132-3. doi: 10.1212/WNL.0000000000002850. Epub 2016 Jun 15.
4
Computed Tomography Perfusion-Based Decision Making for Acute Ischemic Stroke-Missing the Mismatch.基于计算机断层扫描灌注成像的急性缺血性卒中决策制定——遗漏不匹配现象
J Stroke Cerebrovasc Dis. 2017 May;26(5):e78-e79. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.001. Epub 2017 Mar 18.
5
The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.接受静脉溶栓治疗的超急性缺血性卒中患者的血压与侧支循环的关联。
Cerebrovasc Dis. 2015;39(2):130-7. doi: 10.1159/000371339. Epub 2015 Jan 31.
6
Treatment of acute ischemic stroke: Part I: recanalization strategies.急性缺血性卒中的治疗:第一部分:再通策略。
Circulation. 2002 Sep 17;106(12):1563-9. doi: 10.1161/01.cir.0000030406.47365.26.
7
Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.使用基于磁共振成像的患者选择方法,延长急性缺血性脑卒中的静脉溶栓时间窗。
Int J Stroke. 2019 Jul;14(5):483-490. doi: 10.1177/1747493019840938. Epub 2019 Apr 4.
8
Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.急性静脉-动脉血管再通治疗严重缺血性卒中
Stroke. 2002 Jan;33(1):279-82. doi: 10.1161/hs0102.101900.
9
Medical Decision Making: Hyposphagma Prior to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.医学决策:急性缺血性卒中静脉注射组织型纤溶酶原激活剂前的低视力情况
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):e181-2. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.018. Epub 2016 Aug 1.
10
Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.溶栓后卒中患者的远程缺血预处理:激活内源性神经保护的随机研究-设计和 MRI 测量。
Int J Stroke. 2013 Feb;8(2):141-6. doi: 10.1111/j.1747-4949.2012.00786.x. Epub 2012 Mar 30.

引用本文的文献

1
Oliv. Bark Extracts Alleviate MCAO/Reperfusion-Induced Neurological Dysfunction by Suppressing Microglial Inflammation in the Gray Matter.橄榄树皮提取物通过抑制灰质中的小胶质细胞炎症来减轻大脑中动脉闭塞/再灌注诱导的神经功能障碍。
Int J Mol Sci. 2025 Feb 13;26(4):1572. doi: 10.3390/ijms26041572.
2
Chronic hypertension alters the relationship between collateral blood flow cortical cerebral blood flow, and brain tissue oxygenation.慢性高血压改变了侧支血流、皮质脑血流和脑组织氧合之间的关系。
J Cereb Blood Flow Metab. 2024 Nov;44(11):1227-1237. doi: 10.1177/0271678X241258569. Epub 2024 May 28.
3
MRI-guided thrombolysis for lenticulostriate artery stroke within 12 h of symptom onset.

本文引用的文献

1
DEFUSE-3 Trial: Reinforcing Evidence for Extended Endovascular Intervention Time Window for Ischemic Stroke.DEFUSE-3试验:强化缺血性卒中血管内介入治疗时间窗延长的证据
World Neurosurg. 2018 Apr;112:275-276. doi: 10.1016/j.wneu.2018.02.064. Epub 2018 Feb 16.
2
Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset.基于半暗带成像的替奈普酶溶栓治疗在症状发作后24小时内是可行的。
J Stroke. 2018 Jan;20(1):122-130. doi: 10.5853/jos.2017.00178. Epub 2018 Jan 31.
3
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.
MRI 引导下的症状发作 12 小时内的纹状体动脉卒中溶栓治疗。
Sci Rep. 2022 May 6;12(1):7445. doi: 10.1038/s41598-022-11459-3.
4
Dimensions and forms of artefacts in 1.5 T and 3 T MRI caused by cochlear implants.1.5T 和 3T MRI 中人工耳蜗引起的伪影的尺寸和形态。
Sci Rep. 2022 Mar 22;12(1):4884. doi: 10.1038/s41598-022-08988-2.
5
Systematic review protocol to assess artificial intelligence diagnostic accuracy performance in detecting acute ischaemic stroke and large-vessel occlusions on CT and MR medical imaging.系统评价协议,用于评估人工智能在 CT 和 MR 医学成像上检测急性缺血性卒中和大血管闭塞的诊断准确性表现。
BMJ Open. 2021 Mar 10;11(3):e043665. doi: 10.1136/bmjopen-2020-043665.
6
Metabolome Changes in Cerebral Ischemia.脑缺血中的代谢组变化。
Cells. 2020 Jul 7;9(7):1630. doi: 10.3390/cells9071630.
发病后 6 至 24 小时内进行取栓术治疗与缺损和梗死不匹配的脑卒中。
N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.
4
A New DAWN for Imaging-Based Selection in the Treatment of Acute Stroke.基于成像的急性卒中治疗选择的新曙光。
N Engl J Med. 2018 Jan 4;378(1):81-83. doi: 10.1056/NEJMe1713367. Epub 2017 Nov 11.
5
PET imaging of the neurovascular interface in cerebrovascular disease.PET 成像在脑血管疾病中的神经血管界面研究。
Nat Rev Neurol. 2017 Nov;13(11):676-688. doi: 10.1038/nrneurol.2017.129. Epub 2017 Oct 6.
6
Imaging-based selection of patients for acute stroke treatment: Is it ready for prime time?基于影像学的急性中风治疗患者选择:它准备好进入黄金时代了吗?
Neurology. 2017 Jun 13;88(24):2242-2243. doi: 10.1212/WNL.0000000000004051. Epub 2017 May 17.
7
Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke.计算机断层扫描灌注成像预测缺血性卒中再通治疗的反应
Ann Neurol. 2017 Jun;81(6):849-856. doi: 10.1002/ana.24953. Epub 2017 Jun 9.
8
Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study.移动卒中治疗单元院前溶栓与常规治疗的功能结局比较:观察性登记研究。
Lancet Neurol. 2016 Sep;15(10):1035-43. doi: 10.1016/S1474-4422(16)30129-6. Epub 2016 Jul 16.
9
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.低剂量与标准剂量静脉内阿替普酶治疗急性缺血性脑卒中。
N Engl J Med. 2016 Jun 16;374(24):2313-23. doi: 10.1056/NEJMoa1515510. Epub 2016 May 10.
10
Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities.急性卒中成像研究路线图III:急性卒中再灌注临床试验中的成像选择与结果:共识建议及进一步研究重点
Stroke. 2016 May;47(5):1389-98. doi: 10.1161/STROKEAHA.115.012364. Epub 2016 Apr 12.